Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UGA discovery promises to improve drugs used to fight cancer, other diseases

14.01.2013
Even when at rest, the human body is a flurry of activity. Like a microscopic metropolis locked in a state of perpetual rush hour traffic, the trillions of cells that make us who we are work feverishly policing the streets, making repairs, building new structures and delivering important cargo throughout the bustling organic society.
For everything to work properly there must be something to organize and direct the various workers. Enter protein kinases. Like specialized traffic signals, this huge class of proteins is critical for many aspects of cell communication, telling them when to begin work and when to stop.

Now, University of Georgia researchers have discovered that a little-studied part of the protein kinases that once appeared non-functional may actually control the most critical functions of the entire molecule. Their research promises to help improve drugs used to fight a variety of life-threatening diseases, from diabetes to cancer.

"The overall goal of this project was to better understand how these proteins function and what mechanisms control their function," said Natarajan Kannan, a Georgia Cancer Coalition Distinguished Scholar and assistant professor of biochemistry and molecular biology in the Franklin College of Arts and Sciences. "Our research shows that these little-studied dark regions of the protein are directly affecting the molecule's function."

Normally functioning protein kinases perform duties central to the everyday cellular operations within our bodies, but when they become dysfunctional, they can play a major role in the development of numerous serious diseases, including Alzheimer's, diabetes, cardiovascular disease and many forms of cancer.

Scientists have recognized the value of the proteins as therapeutic targets for decades, and numerous drugs, known as protein kinase inhibitors, are commonly prescribed in an attempt to slow or stop the rogue kinases that cause disease. The UGA team hopes its discovery will not only lead to new therapies but also help improve those already in existence.

"This opens a new front on the battle against many diseases, particularly cancer," said Krishnadev Oruganty, a postdoctoral research associate in biochemistry and molecular biology and lead author of a paper detailing the discovery published on Dec. 31 in the early edition of the Proceedings of the National Academy of Sciences USA.

Developing entirely new drugs is an extraordinarily lengthy and expensive process, but this new understanding of how protein kinases switch between "on" and "off" states will make it possible for researchers to modify existing drugs to make them perform better without significant investment.

"These are a very important class of proteins for biomedical industries, and the pharmaceutical industry has already invested billions of dollars in drugs that target these proteins," said Kannan, who is part of the UGA Cancer Center and the Institute of Bioinformatics. "This discovery will have a huge impact on how pharmaceutical companies develop drugs, because subtle modifications of these drugs will make it easier to control them, which will boost their effectiveness."

Kannan and the interdisciplinary team of UGA researchers working on the project are already beginning to design drugs that can selectively inhibit the rogue proteins that cause disease, but they caution that more research is needed to perfect their approach.

Nevertheless, they are confident that this discovery will have a profound impact on the pharmaceutical industry, and on the understanding of the elementary components of life.

"Every fundamental signaling pathway in our cells is controlled by these proteins," Kannan said. "Gaining a deeper understanding of how these kinases work will open doors to a myriad of important new discoveries."

UGA Cancer Center
The University of Georgia Cancer Center is composed of more than 40 teams of researchers from across campus working to discover new drug targets, develop diagnostic tests, create cancer vaccines, and educate the public about cancer treatment and prevention. The center is also committed to educating undergraduate and graduate-level students who will become the next generation of cancer researchers and physicians. For more information on the UGA Cancer Center, see http://cancercenter.uga.edu.

UGA Institute of Bioinformatics
The University of Georgia Institute of Bioinformatics facilitates interactions and research collaborations between experimental biologists, technologists and computational/mathematical scientists to solve complex biological problems. Team members are actively conducting bioinformatics research on genomics, plant genomics, microbial genomics, biomedicine and cancer, pharmaceuticals, glycobiology and statistical sciences. The institute is also responsible for the computing support for campus wide bioinformatics research at UGA. See http://iob.uga.edu for more information.

Natarajan Kannan | EurekAlert!
Further information:
http://www.uga.edu

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>